You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A recent paper describes sample infrastructure for connecting tumor sequence to drugs and trials for use by labs offering oncology NGS-based panels.
New bioinformatics businesses bloomed over the past year in spite of a challenging market and encroachment from instrument vendors and other larger entities.
The new challenge focuses on computational methods for identifying blood gene expression signatures that can be used as markers of smoking exposure.
Participants in the three-day hackathon, to be held early next year, will develop tools for analyzing NGS data in the context of specific research questions.
The study demonstrated the efficacy of using the Oxford Nanopore MinIon and a bespoke computational pipeline to perform metagenomics testing of viral infections in patients.
Congenica and Omicia have signed contracts to interpret data from the first 8,000 patients in the UK's 100,000 Genomes Project.
Roughly a quarter of the five-year investment will support existing and new biomedical and health research efforts to improve patient care and personalize treatments.
The new center will provide a common space for scientists from various disciplines to work on computational and statistical challenges.
As newly-minted GenoFAB mulls commercial models for its GenoCAD DNA design web app, the company is trying to engage with its target market through pilot projects.
The developers of a web-based tool originally designed to track flu virus evolution have released versions of their software that track changes in other troublesome viruses.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.